Enfusion Inc (ENFN) Stock
ENFN is no longer traded. Enfusion was acquired by Clearwater Analytics on April 18, 2025.
Prices on this page are historical; the last trade was April 17, 2025 at $10.76.
Enfusion stock price history
ENFN final trading statistics
- Final close
- $10.76
- Final trading day
- Apr 17, 2025
- Market cap at delisting
- $1.02B
- Shares outstanding
- 94.80M
- Final 52-week range
- $7.83 – $11.80
- Avg. volume (final 3 mo.)
- 1,160,258
- All-time high (split-adj.)
- $22.94 · Nov 2021
- All-time low (split-adj.)
- $7.54 · May 2023
- Return since IPO
- -46.0%
- Beta
- 0.93
- Book value / share
- $0.77
- Price / book
- 13.90
Enfusion annual financials
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2024 | $201.61M | $2.8M | $0.19 |
| FY2023 | $174.53M | $6.0M | $0.14 |
| FY2022 | $150.35M | -$13.3M | $0.18 |
| FY2021 | $111.70M | -$282.2M | -$137.64 |
| FY2020 | $79.56M | $4.1M | — |
Last five fiscal years reported before the delisting; fiscal year ending December. EPS is adjusted (non-GAAP) EPS as reported. Source: company filings via EODHD.
About Enfusion Inc
Enfusion, Inc. provides software-as-a-service solutions for investment management industry in the United States, Europe, the Middle East, Africa, and the Asia Pacific. The company offers Portfolio Management System, which generates a real-time investment book of record that consists of valuation and risk tools, which allows users to analyze aggregated or decomposed portfolio data for chief investment officers (CIOs) and portfolio managers; and Order and Execution Management System that enables portfolio managers, traders, compliance teams, and analysts to electronically communicate trade orders for a variety of asset classes, manage trade orders, and systemically enforce trading regulations and internal guidelines. It also provides Accounting/General Ledger System, a proper double-entry ledger that automates the posting of general ledger journal entries for all cash and securities transactions for chief financial officers, chief operating officers, accountants, and operations teams; Enfusion Analytics System, which enables CIOs, portfolio managers, traders, and analysts to analyze portfolios through time horizons and automate customized visualized reports for internal and external stakeholders; and technology-powered and managed services. Enfusion, Inc. was founded in 1997 and is headquartered in Chicago, Illinois.
Enfusion stock FAQ
What happened to Enfusion stock?
Enfusion was acquired by Clearwater Analytics on April 18, 2025. ENFN stock stopped trading on the NYSE, with a final close of $10.76 on April 17, 2025.
Is ENFN stock still trading?
No. ENFN was delisted from the NYSE on April 18, 2025 and no longer trades on a U.S. exchange.
What was the last price of ENFN stock?
ENFN closed at $10.76 on its final trading day, April 17, 2025, for a market value of about $1.02B.
What were Enfusion's revenue and earnings in its last full fiscal year?
Enfusion reported revenue of $201.61M and net income of $2.8M in fiscal 2024, its last full year as a public company.
When did Enfusion go public?
Enfusion Inc stock began trading on October 21, 2021.